2023 Q4 Form 10-K Financial Statement

#000192998024000073 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $1.566M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $759.4K $3.430M $1.566M
YoY Change 305.79% 118.99% 727.76%
Operating Profit -$3.430M -$1.566M
YoY Change 118.99%
Interest Expense $1.098M $9.953M $5.076M
YoY Change -63.1% 96.1% 570193.26%
% of Operating Profit
Other Income/Expense, Net $326.5K -$1.261M $22.82M
YoY Change -79.61% -105.52% 231.45%
Pretax Income $669.5K $5.266M $21.25M
YoY Change -84.75% -75.22% 233.37%
Income Tax
% Of Pretax Income
Net Earnings $669.5K $5.266M $21.25M
YoY Change -84.75% -75.22% 233.37%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.04 $0.18 $0.49
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $111.8K $111.8K $299.2K
YoY Change -62.62% -62.62% -67.69%
Cash & Equivalents $111.8K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $389.6K
YoY Change -100.0% -100.0% -11.05%
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $111.8K $111.8K $688.7K
YoY Change -83.76% -83.76% -49.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $56.71M $56.71M $357.0M
YoY Change -84.11% -84.11% 1.44%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $56.71M $56.71M $357.0M
YoY Change -84.11% -84.11% 1.32%
TOTAL ASSETS
Total Short-Term Assets $111.8K $111.8K $688.7K
Total Long-Term Assets $56.71M $56.71M $357.0M
Total Assets $56.82M $56.82M $357.7M
YoY Change -84.11% -84.11% 1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.368M $2.368M $614.8K
YoY Change 285.15% 285.15% 345.79%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.726M $4.726M $626.7K
YoY Change 654.18% 654.18% 318.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.480M $3.480M $2.219M
YoY Change 56.81% 56.81% -88.88%
Total Long-Term Liabilities $3.480M $3.480M $2.219M
YoY Change 56.81% 56.81% -88.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.726M $4.726M $626.7K
Total Long-Term Liabilities $3.480M $3.480M $2.219M
Total Liabilities $8.206M $8.206M $2.846M
YoY Change 188.35% 188.35% -85.85%
SHAREHOLDERS EQUITY
Retained Earnings -$8.095M
YoY Change 275.27%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.61M $48.61M $354.8M
YoY Change
Total Liabilities & Shareholders Equity $56.82M $56.82M $357.7M
YoY Change -84.11% -84.11% 1.13%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income $669.5K $5.266M $21.25M
YoY Change -84.75% -75.22% 233.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$326.5K -$1.256M -$626.6K
YoY Change 481.32% 100.52% -29.75%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $67.95M $310.2M $0.00
YoY Change -100.0%
Cash From Investing Activities $67.95M $310.2M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$68.20M -$311.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -67.64M -309.2M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -326.5K -1.256M -626.6K
Cash From Investing Activities 67.95M 310.2M 0.000
Cash From Financing Activities -67.64M -309.2M 0.000
Net Change In Cash -17.33K -187.3K -626.6K
YoY Change -69.14% -70.1% -167.69%
FREE CASH FLOW
Cash From Operating Activities -$326.5K -$1.256M -$626.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001880441
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
#18195
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
34500000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022 bfac Accretion For Shares Subject To Redemption
AccretionForSharesSubjectToRedemption
-5075607 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
0 shares
CY2023Q2 bfac Additional Per Share Amount Deposited Into The Trust Account
AdditionalPerShareAmountDepositedIntoTheTrustAccount
0.03
bfac Additional Per Share Amount Deposited Into The Trust Account
AdditionalPerShareAmountDepositedIntoTheTrustAccount
0.03
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 bfac Percent Of Gross Proceeds To Equity Proceeds
PercentOfGrossProceedsToEquityProceeds
0.6 pure
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
45000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0 usd
CY2022Q4 bfac Preferred Stock Shares Authorized In Equity
PreferredStockSharesAuthorizedInEquity
1000000 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41158
CY2023 dei Entity Registrant Name
EntityRegistrantName
BATTERY FUTURE ACQUISITION CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1618517
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
8 The Green, #18195
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Dover
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19901
CY2023 dei City Area Code
CityAreaCode
929
CY2023 dei Local Phone Number
LocalPhoneNumber
465-9707
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
121231405 usd
CY2023 dei Auditor Name
AuditorName
Bush & Associates CPA LLC
CY2023 dei Auditor Location
AuditorLocation
Henderson
CY2023 dei Auditor Firm
AuditorFirmId
6797
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299149 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
389583 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
111819 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
688732 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
0 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
0 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
56708101 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
356976495 usd
CY2023Q4 us-gaap Assets
Assets
56819920 usd
CY2022Q4 us-gaap Assets
Assets
357665227 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2368029 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
614839 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2358135 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11820 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4726164 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
626659 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3479807 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2219165 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8205971 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2845824 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
56707840 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
356975607 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
34500000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8094754 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2157067 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8093891 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2156204 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56819920 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
357665227 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3430328 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1566455 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-3430328 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1566455 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1260642 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17743846 usd
CY2023 bfac Interest Earned On Related Party Promissory Note
InterestEarnedOnRelatedPartyPromissoryNote
-76149 usd
CY2023 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
80059 usd
CY2022 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
9953034 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
5075607 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8696302 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22819453 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
5265974 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21252998 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18333595 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21252998 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2156204 usd
CY2023 bfac Accretion For Shares Subject To Redemption
AccretionForSharesSubjectToRedemption
3628263 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5265974 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8093891 usd
CY2023 us-gaap Profit Loss
ProfitLoss
5265974 usd
CY2022 us-gaap Profit Loss
ProfitLoss
21252998 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
9953034 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
5075607 usd
CY2023 bfac Interest On Working Capital Loan Related Party
InterestOnWorkingCapitalLoanRelatedParty
27180 usd
CY2023 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
-1260642 usd
CY2022 us-gaap Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1
ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
17743846 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
389583 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
48402 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
414521 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1753190 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
476923 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1256465 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-626609 usd
CY2023 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
311471428 usd
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1250000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
310221428 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2319135 usd
CY2023 bfac Proceeds From Redemption Of Common Stock
ProceedsFromRedemptionOfCommonStock
-311471428 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-309152293 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-187330 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-626609 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299149 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
925758 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299149 usd
CY2023 bfac Change In Value Of Class A Ordinary Shares Subject To Possible Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToPossibleRedemption
11203661 usd
CY2022 bfac Change In Value Of Class A Ordinary Shares Subject To Possible Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToPossibleRedemption
0 usd
CY2021Q4 us-gaap Cash
Cash
979690 usd
CY2023Q2 us-gaap Share Price
SharePrice
0.024
CY2023Q4 bfac Cash In Hand
CashInHand
123724 usd
CY2023 bfac Initial Business Combination Description
InitialBusinessCombinationDescription
the Founder Shares will be released from the lockup if (1) the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in its shareholders having the right to exchange their shares for cash, securities or other property
CY2023Q4 bfac Preferred Stock Shares Authorized In Equity
PreferredStockSharesAuthorizedInEquity
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001

Files In Submission

Name View Source Status
0001929980-24-000073-index-headers.html Edgar Link pending
0001929980-24-000073-index.html Edgar Link pending
0001929980-24-000073.txt Edgar Link pending
0001929980-24-000073-xbrl.zip Edgar Link pending
bfac-20231231.xsd Edgar Link pending
bfac_10k.htm Edgar Link pending
bfac_ex231.htm Edgar Link pending
bfac_ex311.htm Edgar Link pending
bfac_ex321.htm Edgar Link pending
bfac_ex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
bfac-20231231_cal.xml Edgar Link unprocessable
bfac-20231231_def.xml Edgar Link unprocessable
bfac-20231231_lab.xml Edgar Link unprocessable
bfac-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfac_10k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending